First Weight-Loss Pill From Lilly Shows Promising Results
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them
Fewer Americans Traveled for Abortions in 2024, Report Finds
Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya
WHO Announces Completion of Draft Pandemic Agreement
Proposal includes steps that need to be taken to strengthen preparedness, readiness, and health system functions and resilience
Longer Exposure to Antidepressants Increases Risk for Sudden Cardiac Death
Generally, difference in risk associated with antidepressant exposure decreases with age
Flares Occur Frequently in Generalized Pustular Psoriasis
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed
FDA Approves Self-Injection of Vyvgart Hytrulo
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy
Tirzepatide Dispensations Increased Rapidly After Approval
By December 2023, 12.3 percent of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM
Adverse Events From Semaglutide Seen in the ED Usually GI-Related
Most common gastrointestinal issues seen are nausea/vomiting, abdominal pain, and diarrhea
